Coronary stents are small interventional device used for opening the blocked arteries and for prevention of re-narrowing of the arteries. The global coronary stents market report serves are a valuable tool for evaluation of coronary stents present market scenario and the trends over the forecast period of 2016 – 2026. The report delivers in depth analysis of factors driving as well as restraining the market growth and also enlightens further market opportunity for the manufacturers. Report also covers key developments and company’s strategies to grab the market share.
Grab Sample of this Report at: @
Market Dynamics
Increasing product launches coupled with increasing geographical approval in drug eluting coronary stents is propelling growth of the coronary stents market. For instance, in May 2018, Abbott received the U.S. FDA approval for XIENCE Sierra, the new generation of everolimus-eluting coronary stent. The XIENCE received approval from the Japan’s regulatory body in April 2018, and CE mark from European regulatory bodies in 2017. Furthermore, companies are also evaluating and launching products with novel material, such as with metal like cobalt chromium and fully biodegradable stents. For instance, in 2017, Biotronik received FDA approval for PRO-Kinetic energy cobalt chromium-based bare metal coronary stent system to treat coronary artery blockage. However, coronary stents market is also subjected to the factors such as stringent regulatory approval policies for the interventional devices and medical complications such as restenosis and thrombosis, which are expected to restrain coronary stents market growth.
Key features of the study:
This report provides in-depth analysis of the coronary stents market and its application, market size (US$ Million) and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global coronary stents market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
Key companies covered as a part of this study include Boston Scientific Corporation, Abbott, Medtronic plc, B. Braun Melsungen AG, Stentsy SA, Terumo Interventional Systems, Kyoto Medical Planning Co., Ltd., QualiMed, Elixir Medical Corporation, ENDOCOR GmbH, BIOTRONIK SE & Co. KG, Amaranth Medical, Inc. and Arterial Remodeling Technologies SA
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, distribution channel upgrades, market expansion and marketing tactics.
The global coronary stents market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers of coronary stents, research and consulting firms, new entrants, and financial analysts
Various strategy matrices used in analyzing the coronary stents market would provide stakeholders vital inputs to make strategic decisions accordingly
Detailed Segmentation:
Global Coronary Stents Market, By Product Type:
Bare-Metal Stents
Drug Eluting Stents
Bioabsorbable Stents
Global Coronary Stents Market, By Material:
Metallic
Stainless Steel
Silicon Carbide
Titanium Nitride Oxide
Cobalt Chromium
Platinum Chromium
Others
Polymeric
Non-degradable / Permanent Stents
Degradable / Temporary Stents
Global Coronary Stents Market, By End Users:
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Global Coronary Stents Market, By Region:
North America
By Product Type:
Bare-Metal Stents
Drug Eluting Stents
Bioabsorbable Stents
By Material:
Metallic
Stainless Steel
Silicon Carbide
Titanium Nitride Oxide
Cobalt Chromium
Platinum Chromium
Others
Polymeric
Non-degradable / Permanent Stents
Degradable / Temporary Stents
By End Users:
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
By Country:
U.S.
Canada
Latin America
By Product Type:
Bare-Metal Stents
Drug Eluting Stents
Bioabsorbable Stents
By Material:
Metallic
Stainless Steel
Silicon Carbide
Titanium Nitride Oxide
Cobalt Chromium
Platinum Chromium
Others
Polymeric
Non-degradable / Permanent Stents
Degradable / Temporary Stents
By End Users:
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
By country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type:
Bare-Metal Stents
Drug Eluting Stents
Bioabsorbable Stents
By Material:
Metallic
Stainless Steel
Silicon Carbide
Titanium Nitride Oxide
Cobalt Chromium
Platinum Chromium
Others
Polymeric
Non-degradable / Permanent Stents
Degradable / Temporary Stents
By End Users:
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
By country:
Germany
U.K.
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type:
Bare-Metal Stents
Drug Eluting Stents
Bioabsorbable Stents
By Material:
Metallic
Stainless Steel
Silicon Carbide
Titanium Nitride Oxide
Cobalt Chromium
Platinum Chromium
Others
Polymeric
Non-degradable / Permanent Stents
Degradable / Temporary Stents
By End Users:
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
By country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
By Product Type:
Bare-Metal Stents
Drug Eluting Stents
Bioabsorbable Stents
By Material:
Metallic
Stainless Steel
Silicon Carbide
Titanium Nitride Oxide
Cobalt Chromium
Platinum Chromium
Others
Polymeric
Non-degradable / Permanent Stents
Degradable / Temporary Stents
By End Users:
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
By country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Bare-Metal Stents
Drug Eluting Stents
Bioabsorbable Stents
By Material:
Metallic
Stainless Steel
Silicon Carbide
Titanium Nitride Oxide
Cobalt Chromium
Platinum Chromium
Others
Polymeric
Non-degradable / Permanent Stents
Degradable / Temporary Stents
By End Users:
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
By country:
North Africa
Central Africa
South Africa
Company Profiles
Boston Scientific Corporation*
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategies
Abbott
Medtronic plc
B. Braun Melsungen AG
Stentsy SA
Terumo Interventional Systems
Kyoto Medical Planning Co., Ltd.
QualiMed
Elixir Medical Corporation
ENDOCOR GmbH
BIOTRONIK SE & Co. KG
Amaranth Medical, Inc.
Arterial Remodeling Technologies SA
Get Exclusive Discount at: @
“*” marked represents similar segmentation in other categories in the respective section.
Industry Forecast Research 